GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultimovacs ASA (OSL:ULTI) » Definitions » Quick Ratio

Ultimovacs ASA (OSL:ULTI) Quick Ratio

: 4.85 (As of Dec. 2023)
View and export this data going back to 2019. Start your Free Trial

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Ultimovacs ASA's quick ratio for the quarter that ended in Dec. 2023 was 4.85.

Ultimovacs ASA has a quick ratio of 4.85. It generally indicates good short-term financial strength.

The historical rank and industry rank for Ultimovacs ASA's Quick Ratio or its related term are showing as below:

OSL:ULTI' s Quick Ratio Range Over the Past 10 Years
Min: 4.14   Med: 11.44   Max: 20.12
Current: 4.85

During the past 9 years, Ultimovacs ASA's highest Quick Ratio was 20.12. The lowest was 4.14. And the median was 11.44.

OSL:ULTI's Quick Ratio is ranked better than
59.85% of 1554 companies
in the Biotechnology industry
Industry Median: 3.585 vs OSL:ULTI: 4.85

Ultimovacs ASA Quick Ratio Historical Data

The historical data trend for Ultimovacs ASA's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultimovacs ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Quick Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.12 16.36 11.44 9.49 4.85

Ultimovacs ASA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Quick Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.49 7.27 9.06 6.81 4.85

Competitive Comparison

For the Biotechnology subindustry, Ultimovacs ASA's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ultimovacs ASA Quick Ratio Distribution

For the Biotechnology industry and Healthcare sector, Ultimovacs ASA's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Ultimovacs ASA's Quick Ratio falls into.



Ultimovacs ASA Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Ultimovacs ASA's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(272.117-0)/56.109
=4.85

Ultimovacs ASA's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(272.117-0)/56.109
=4.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ultimovacs ASA  (OSL:ULTI) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Ultimovacs ASA Quick Ratio Related Terms

Thank you for viewing the detailed overview of Ultimovacs ASA's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ultimovacs ASA (OSL:ULTI) Business Description

Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.

Ultimovacs ASA (OSL:ULTI) Headlines

No Headlines